Use of Anti-IL-20 antibody for treating osteoporosis (as amended)

Ming-Shi Chang (Inventor)

Research output: Patent

Abstract

Treatment of rheumatoid arthritis and osteoporosis using an anti-IL-20 antibody 7E, and optionally, in combination with an etanercept polypeptide.
Original languageEnglish
Patent number7837994
Publication statusPublished - 2010 Apr 8

Fingerprint

Osteoporosis
Rheumatoid Arthritis
Peptides
Antibodies
interleukin 20
Etanercept

Cite this

@misc{8a4c58db2ffc4744befddfcd245e80d6,
title = "Use of Anti-IL-20 antibody for treating osteoporosis (as amended)",
abstract = "Treatment of rheumatoid arthritis and osteoporosis using an anti-IL-20 antibody 7E, and optionally, in combination with an etanercept polypeptide.",
author = "Ming-Shi Chang",
year = "2010",
month = "4",
day = "8",
language = "English",
type = "Patent",
note = "7837994",

}

TY - PAT

T1 - Use of Anti-IL-20 antibody for treating osteoporosis (as amended)

AU - Chang, Ming-Shi

PY - 2010/4/8

Y1 - 2010/4/8

N2 - Treatment of rheumatoid arthritis and osteoporosis using an anti-IL-20 antibody 7E, and optionally, in combination with an etanercept polypeptide.

AB - Treatment of rheumatoid arthritis and osteoporosis using an anti-IL-20 antibody 7E, and optionally, in combination with an etanercept polypeptide.

M3 - Patent

M1 - 7837994

ER -